Tissue Engineering Company Cook MyoSite Incorporated Opens New Headquarters in Pittsburgh
Cook MyoSite Incorporated, the cell therapy division of Cook Medical, is hosting an open house Thursday, May 10th from 6 p. m. -- 9 p. m. to celebrate the opening of the new 22,000 sq. ft. headquarters. The reception will take place at the facility's location at 105 Delta Drive, Pittsburgh, PA 15238. Carl Cook, president of Cook MyoSite, welcomes the community to attend, meet the Cook team and congratulate co-founders Drs. Michael Chancellor and Johnny Huard. The company has completed the first North American trial using muscle-derived cells to treat urinary incontinence and has started a multi-center trial in Canada. First United States trial is expect to begin soon.
Pittsburgh, Pa. (PRWEB) May 9, 2007
Cook MyoSite Incorporated, the cell therapy division of Cook Medical, is hosting an open house Thursday, May 10th from 6 p. m. -- 9 p. m. to celebrate the opening of the new 22,000 sq. ft. headquarters. All members of the University of Pittsburgh and University of Pittsburgh Medical Center (UPMC) community are welcome to attend.
Building on the pioneering work of University of Pittsburgh researchers, and under a license agreement with the University, Cook MyoSite Inc., is developing technology involving the use of autologous muscle-derived cells for treating urinary incontinence and other diseases. These autologous cells - cells taken from the patient - may also have the ability to repair other damaged tissues.
Cook MyoSite co-founders, Michael Chancellor, M. D., and Johnny Huard, Ph. D., partnered in 1997 to develop muscle stem cell based therapies. In 2001, with funding from Indiana-based Cook Medical, they founded Cook MyoSite. The company has since then completed the first North American trial using muscle-derived cells to treat urinary incontinence and has started a multi-center trial in Canada. The first U. S. trial is scheduled to start at University of Pittsburgh Medical Center in 2007. Cook MyoSite's new headquarters is located at the Regional Industrial Development Corporation (RIDC) Park and outfitted with state of the art U. S. Food and Drug Administration (FDA) Good Manufacturing Practice (GMP) cellular manufacturing equipment.
Dr. Huard is the deputy director of the McGowan Institute for Regenerative Medicine (MIRM); Cellular Therapeutic Pillar and an associate director of the Pittsburgh Tissue Engineering Initiative (PTEI). Dr. Chancellor is a professor in the departments of urology, obstetrics-gynecology and at the McGowan Institute for Regenerative Medicine at the University of Pittsburgh School of Medicine.
The reception will take place at the facility's location at 105 Delta Drive, Pittsburgh, PA 15238. Carl Cook, president of Cook MyoSite, welcomes the community to attend, meet the Cook team and congratulate Drs. Chancellor and Huard.
About Cook Medical
Cook Medical, the world's largest privately held manufacturer of medical devices, has pioneered numerous innovative clinical technologies for diagnostic and therapeutic procedures since its founding in 1963. Known worldwide as a leading developer, manufacturer and global distributor of medical therapies in the fields of radiology, cardiology, urology, endovascular therapy, women's health, critical care medicine, surgery and soft tissue repair, gastroenterology, bone access, oncology and cellular and genetic treatments, the company won the prestigious Medical Device Manufacturer of the Year Award for 2006 from Medical Device & Diagnostic Industry magazine. For more information, visit www. cookmedical. com.
###
